MORE►
CerSci
Lucas Rodriguez, CerSci [Photo: Skyler Fike]
Dallas-based Biotech CerSci Acquired by ACADIA Pharmaceutical in $52.5M Deal
by Quincy Preston | Aug 25, 2020
CerSci shareholders could net another $887 million in milestones and tiered royalties. The clinical-stage startup, which launched in 2015, is developing a new generation of non-opioid meds to treat acute and chronic pain.
by Lance Murray |
Sep 7, 2018
Also, you'll learn about advances to treat Duchenne muscular dystrophy and migraines. Here are some of the research projects underway in North Texas that could make lives better.
MORE►
